Paracetamol brand Panadol stops production in Pakistan

There is currently a national shortage of the popular paracetamol brand Panadol due to a major international pharmaceutical business stopped production.

The manufacturer, who has been requesting permission to raise the price of Panadol, claims that production was no longer financially sustainable.

Acetaminophen, usually referred to as paracetamol, is a drug used to treat fever and mild to moderate discomfort.

In flood-affected areas where people are afflicted with a variety of illnesses, the commonly used brand of paracetamol is in high demand. With a rise in dengue cases recently recorded, demand has also increased in urban centers.

The Drug Regulatory Authority of Pakistan reportedly issued a summary to the health ministry requesting an increase of Re1 per tablet, but the federal cabinet rejected the document, according to the Pharmaceutical Manufacturing Association of Pakistan.

According to the association, the producer could sell the medicine for less than it would cost to produce it.

According to the pharmaceutical industry, production of the 450 million tablets per month has been fully stopped. The DRAP has been properly informed that some of the tablets sold by pharmacies are fake.